Research Analysis: Use Neuromodulation for CRPS Sooner not Later

A research analysis published in Neuromodulation: Technology at the Neural Interface concluded that clinicians should consider spinal cord stimulation (SCS) earlier than as a last resort for the treatment of complex regional pain syndrome (CRPS).  SCS has been FDA-approved for the treatment of neuropathic trunk and limb pain since 1989 and involves a slender electrical lead implanted under the skin of the back to deliver a mild electrical current to the spinal cord. The analysis found that to facilitate functional rehabilitation in CRPS, SCS should be considered as soon as more conservative therapies have failed – after perhaps three months. Read a news report here.

Posted on August 4, 2013

Related Content

• Stem Cells to the Rescue in Prevention of Osteoarthritis
• Loperamide: The Newest Drug of Abuse Instead of Opioid Narcotics?
• Women who Catastrophize, More Likely to be Prescribed Opioids for Pain
• A Vaccine that Blocks Psychoactive Sensations of Heroin in the Brain?
• Don't Rely on Corticosteroids for Osteoarthritis Pain Control
• Geriatric Pain: A Possible Predictor of Dementia, Memory Decline
• Addiction Medicine: Helping Patients with Substance Use Disorders
• Advice: Help Building Provider Confidence with Chronic Pain Patients
• Copaiba as an Essential Oil: Snake Oil Therapy for Arthritis Relief?
• Pain Management and the Role of Psychology